Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Tempus AI, Inc. - Class A Common Stock (NQ:TEM)

48.83 -0.31 (-0.63%)

Streaming Delayed Price Updated: 4:00 PM EDT, Mar 24, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	2,616,644
Open	48.46
Bid (Size)	48.50 (100)
Ask (Size)	48.75 (1,500)
Prev. Close	49.14
Today's Range	47.69 - 49.37
52wk Range	36.22 - 104.32
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Want $1 Million in Retirement? Invest $10,000 in These 2 AI Stocks and Hold for 10 Years. ↗

March 21, 2026

AI is rewriting drug discovery. Recursion Pharmaceuticals and Tempus AI might be the platforms that turn early investors into millionaires.

Via The Motley Fool

Tempus and Blood Cancer United® Announce Collaboration to Develop One Of the Largest Pediatric Acute Myeloid Leukemia Real-World Data Registries

March 17, 2026

From Tempus AI, Inc.

Via Business Wire

Performance

YTD	-21.7%	-21.7%
1 Month	-14.8%	-14.8%
3 Month	-25.9%	-25.9%
6 Month	-43.1%	-43.1%
1 Year	-17.2%	-17.2%

More News

Tempus Announces Study Highlighting the Role of Advanced Genomic Profiling Features in Identifying Clinically Actionable Findings

March 11, 2026

From Tempus AI, Inc.

Via Business Wire

Tempus AI Inc (NASDAQ:TEM) Reports Strong Q4 Revenue Beat and First Positive Adjusted EBITDA ↗

February 24, 2026

Via Chartmill

Tempus Announces Strategic Collaboration Agreement with Merck to Accelerate AI-Driven Precision Medicine

March 03, 2026

From Tempus AI, Inc.

Via Business Wire

MarketBeat Week in Review – 02/23 - 02/27 ↗

February 28, 2026

Via MarketBeat

After a Near 50% Drop, Tempus AI Could Be Ripe for a Rebound ↗

February 27, 2026

Via MarketBeat

Tempus to Participate in the Morgan Stanley Technology, Media & Telecom Conference

February 26, 2026

From Tempus AI, Inc.

Via Business Wire

Tempus AI Sold Off After a Beat—But the Rebound Case Is Building ↗

February 25, 2026

Via MarketBeat

Tempus Reports Fourth Quarter and Full Year 2025 Results

February 24, 2026

From Tempus AI, Inc.

Via Business Wire

Tempus Announces Novel Pan-Cancer HRD-RNA Algorithm

February 18, 2026

From Tempus AI, Inc.

Via Business Wire

Tempus Announces Collaboration with Median Technologies to Integrate AI-Powered Lung Cancer Screening into the Pixel Platform

February 12, 2026

From Tempus AI, Inc.

Via Business Wire

Tempus to Report Fourth Quarter and Full Year 2025 Financial Results on February 24

February 10, 2026

From Tempus AI, Inc.

Via Business Wire

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗

February 05, 2026

Via The Motley Fool

Ambry’s Contributions to MAVEs Support Thousands of Patient Reclassifications and Expand to New Genes

February 04, 2026

From Ambry Genetics

Via Business Wire

Ambry Genetics Announces One Millionth Test Leveraging RNA to Improve Diagnostic Accuracy and Yield

February 02, 2026

From Ambry Genetics

Via Business Wire

Here Are Congresswoman Nancy Pelosi's Initial Stock Moves in 2026: They Include Nvidia, Alphabet, and Amazon Stocks, and Others ↗

February 01, 2026

Via The Motley Fool

Tempus Reveals Its AI-Driven IPS Test More Accurately Predicts Immunotherapy Benefit Compared to Conventional Biomarkers

January 27, 2026

From Tempus AI, Inc.

Via Business Wire

Pelosi’s Bullish 2026 Buy List: AI, Power & Dividends ↗

January 26, 2026

Via MarketBeat

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗

January 22, 2026

Via The Motley Fool

Tempus Announces the Launch of Paige Predict

January 21, 2026

From Tempus AI, Inc.

Via Business Wire

Why Tempus AI Stock Rose Today ↗

January 12, 2026

Via The Motley Fool

Tempus and NYU Langone Health Announce Strategic Collaboration to Advance Precision Oncology

January 12, 2026

From Tempus

Via Business Wire

Northwestern Medicine Selects Tempus to Expand Genomic Testing

January 12, 2026

From Tempus AI, Inc.

Via Business Wire

Tempus AI Stock Soars After Posting Triple-Digit Diagnostics Growth ↗

January 12, 2026

Via Benzinga

Frequently Asked Questions

Is Tempus AI, Inc. - Class A Common Stock publicly traded?

Yes, Tempus AI, Inc. - Class A Common Stock is publicly traded.

What exchange does Tempus AI, Inc. - Class A Common Stock trade on?

Tempus AI, Inc. - Class A Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Tempus AI, Inc. - Class A Common Stock?

The ticker symbol for Tempus AI, Inc. - Class A Common Stock is TEM on the Nasdaq Stock Market

What is the current price of Tempus AI, Inc. - Class A Common Stock?

The current price of Tempus AI, Inc. - Class A Common Stock is 48.83

When was Tempus AI, Inc. - Class A Common Stock last traded?

The last trade of Tempus AI, Inc. - Class A Common Stock was at 03/24/26 04:00 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.